MariMed (MRMD) CEO Jon Levine adds 60,000 shares in open-market buys
Rhea-AI Filing Summary
MariMed Inc. President and CEO Jon R. Levine reported open-market purchases of 60,000 shares of common stock on May 22, 2026. The buys were executed at prices of $0.0745, $0.0750, and $0.0767 per share. Following these purchases, he directly owns 21,307,986 common shares.
An additional 6,684,640 common shares are held indirectly by the Jon Levine Family Trust for the benefit of his spouse and children. Levine disclaims beneficial ownership of the trust-held shares, meaning they are attributed to the trust rather than to him personally.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 60,000 shares
Net Buy
4 txns
Insider
Levine Jon R
Role
President and CEO
Bought
60,000 shs ($4K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock | 3,000 | $0.0767 | $230.10 |
| Purchase | Common stock | 37,000 | $0.075 | $3K |
| Purchase | Common stock | 20,000 | $0.0745 | $1K |
| holding | Common stock | -- | -- | -- |
Holdings After Transaction:
Common stock — 21,307,986 shares (Direct);
Common stock — 6,684,640 shares (Indirect, By the Jon Levine Family Trust)
Footnotes (1)
- F1. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Total shares purchased: 60,000 shares
Purchase price 1: $0.0745 per share
Purchase price 2: $0.0750 per share
+3 more
6 metrics
Total shares purchased
60,000 shares
Open-market buys on May 22, 2026
Purchase price 1
$0.0745 per share
Common stock open-market purchase
Purchase price 2
$0.0750 per share
Common stock open-market purchase
Purchase price 3
$0.0767 per share
Common stock open-market purchase
Direct holdings after trades
21,307,986 shares
Common stock directly owned after purchases
Family trust holdings
6,684,640 shares
Held by the Jon Levine Family Trust; beneficial ownership disclaimed
Key Terms
open-market purchase, beneficial ownership, Section 16, Family Trust
4 terms
open-market purchase financial
"Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
Family Trust financial
"By the Jon Levine Family Trust"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did MariMed (MRMD) report for Jon R. Levine?
MariMed reported that President and CEO Jon R. Levine bought 60,000 shares of common stock in open-market transactions. These trades on May 22, 2026 occurred at prices between $0.0745 and $0.0767 per share, increasing his direct ownership stake.
Were there any MariMed (MRMD) insider sales reported for Jon R. Levine?
No insider sales were reported for Jon R. Levine in this Form 4. The filing shows three open-market purchases totaling 60,000 shares and one holding entry, with no dispositions, gifts, tax withholdings, or derivative exercises disclosed in the transaction summary.